USANA said its core nutrition business was in line with expectations in Q2 2026, but near-term issues at its Hiya and Rise Wellness ventures pressured results. The company lowered its full-year outlook due to these challenges. Net impact is cautious for the stock as guidance risk outweighs stable core performance.
USANA said its core nutrition business was in line with expectations in Q2 2026, but near-term issues at its Hiya and Rise Wellness ventures pressured results. The company lowered its full-year outlook due to these challenges. Net impact is cautious for the stock as guidance risk outweighs stable core performance.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly negative
Sentiment Score
-0.25
Ticker Sentiment
